Literature DB >> 29425462

Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.

Jason M Elinoff1, Richa Agarwal2, Christopher F Barnett3, Raymond L Benza2, Michael J Cuttica4, Ahmed M Gharib5, Michael P Gray6, Paul M Hassoun7, Anna R Hemnes8, Marc Humbert9, Todd M Kolb7, Tim Lahm10,11, Jane A Leopold12, Stephen C Mathai7, Vallerie V McLaughlin13, Ioana R Preston14, Erika B Rosenzweig15, Oksana A Shlobin16, Virginia D Steen17, Roham T Zamanian18, Michael A Solomon1,19.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29425462      PMCID: PMC6058980          DOI: 10.1164/rccm.201710-2093PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  116 in total

Review 1.  Pulmonary veno-occlusive disease.

Authors:  J Mandel; E J Mark; C A Hales
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

Review 2.  Pulmonary hypertension in patients with interstitial lung diseases.

Authors:  Jay H Ryu; Michael J Krowka; Patricia A Pellikka; Karen L Swanson; Michael D McGoon
Journal:  Mayo Clin Proc       Date:  2007-03       Impact factor: 7.616

3.  Clinical Relevance of Fluid Challenge in Patients Evaluated for Pulmonary Hypertension.

Authors:  Michele D'Alto; Emanuele Romeo; Paola Argiento; Yoshiki Motoji; Anna Correra; Giovanni Maria Di Marco; Agostino Mattera Iacono; Rosaria Barracano; Antonello D'Andrea; Gaetano Rea; Berardo Sarubbi; Maria Giovanna Russo; Robert Naeije
Journal:  Chest       Date:  2016-08-26       Impact factor: 9.410

4.  Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.

Authors:  Christian F Opitz; Marius M Hoeper; J Simon R Gibbs; Harald Kaemmerer; Joanna Pepke-Zaba; J Gerry Coghlan; Laura Scelsi; Michele D'Alto; Karen M Olsson; Silvia Ulrich; Werner Scholtz; Uwe Schulz; Ekkehard Grünig; Carmine D Vizza; Gerd Staehler; Leonhard Bruch; Doerte Huscher; David Pittrow; Stephan Rosenkranz
Journal:  J Am Coll Cardiol       Date:  2016-07-26       Impact factor: 24.094

5.  Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Authors:  Margaret M Redfield; Horng H Chen; Barry A Borlaug; Marc J Semigran; Kerry L Lee; Gregory Lewis; Martin M LeWinter; Jean L Rouleau; David A Bull; Douglas L Mann; Anita Deswal; Lynne W Stevenson; Michael M Givertz; Elizabeth O Ofili; Christopher M O'Connor; G Michael Felker; Steven R Goldsmith; Bradley A Bart; Steven E McNulty; Jenny C Ibarra; Grace Lin; Jae K Oh; Manesh R Patel; Raymond J Kim; Russell P Tracy; Eric J Velazquez; Kevin J Anstrom; Adrian F Hernandez; Alice M Mascette; Eugene Braunwald
Journal:  JAMA       Date:  2013-03-27       Impact factor: 56.272

6.  Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial.

Authors:  Ganesh Raghu; Rachel Million-Rousseau; Adele Morganti; Loyc Perchenet; Juergen Behr
Journal:  Eur Respir J       Date:  2013-05-16       Impact factor: 16.671

7.  Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis.

Authors:  Steven D Nathan; Oksana A Shlobin; Shahzad Ahmad; Jim Koch; Scott D Barnett; Niv Ad; Nelson Burton; Kevin Leslie
Journal:  Respiration       Date:  2008-01-24       Impact factor: 3.580

Review 8.  Pulmonary hypertension in interstitial lung disease.

Authors:  J Behr; J H Ryu
Journal:  Eur Respir J       Date:  2008-06       Impact factor: 16.671

9.  Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.

Authors:  Ganesh Raghu; Juergen Behr; Kevin K Brown; Jim J Egan; Steven M Kawut; Kevin R Flaherty; Fernando J Martinez; Steven D Nathan; Athol U Wells; Harold R Collard; Ulrich Costabel; Luca Richeldi; Joao de Andrade; Nasreen Khalil; Lake D Morrison; David J Lederer; Lixin Shao; Xiaoming Li; Patty S Pedersen; A Bruce Montgomery; Jason W Chien; Thomas G O'Riordan
Journal:  Ann Intern Med       Date:  2013-05-07       Impact factor: 25.391

10.  Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database.

Authors:  Kiran K Khush; Gudaye Tasissa; Javed Butler; Dana McGlothlin; Teresa De Marco
Journal:  Am Heart J       Date:  2009-04-23       Impact factor: 4.749

View more
  9 in total

1.  Reply to Voelkel and Newman: The Light at the End of the Long Pulmonary Hypertension Tunnel Brightens.

Authors:  Jason M Elinoff; Marc Humbert; Michael A Solomon
Journal:  Am J Respir Crit Care Med       Date:  2018-09-15       Impact factor: 21.405

Review 2.  Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.

Authors:  George Hung; Valentina Mercurio; Steven Hsu; Stephen C Mathai; Ami A Shah; Monica Mukherjee
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

3.  PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension.

Authors:  Yapeng Cao; Xiaoyu Zhang; Lina Wang; Qiuhua Yang; Qian Ma; Jiean Xu; Jingjing Wang; Laszlo Kovacs; Ramon J Ayon; Zhiping Liu; Min Zhang; Yaqi Zhou; Xianqiu Zeng; Yiming Xu; Yong Wang; David J Fulton; Neal L Weintraub; Rudolf Lucas; Zheng Dong; Jason X-J Yuan; Jennifer C Sullivan; Louise Meadows; Scott A Barman; Chaodong Wu; Junmin Quan; Mei Hong; Yunchao Su; Yuqing Huo
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-18       Impact factor: 11.205

4.  Renin-Angiotensin-Aldosterone System Inhibitor Use and Mortality in Pulmonary Hypertension: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking Database.

Authors:  Tim Lahm; Edward Hess; Anna E Barón; Thomas M Maddox; Mary E Plomondon; Gaurav Choudhary; Bradley A Maron; Roham T Zamanian; Peter J Leary
Journal:  Chest       Date:  2020-10-05       Impact factor: 9.410

5.  Diagnosis of pulmonary hypertension.

Authors:  Adaani Frost; David Badesch; J Simon R Gibbs; Deepa Gopalan; Dinesh Khanna; Alessandra Manes; Ronald Oudiz; Toru Satoh; Fernando Torres; Adam Torbicki
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

6.  Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease.

Authors:  Kari R Gillmeyer; Donald R Miller; Mark E Glickman; Shirley X Qian; Elizabeth S Klings; Bradley A Maron; Joseph T Hanlon; Seppo T Rinne; Renda S Wiener
Journal:  Pulm Circ       Date:  2021-04-01       Impact factor: 3.017

7.  An explorative metabolomic analysis of the endothelium in pulmonary hypertension.

Authors:  J Carlsen; H H Henriksen; I Marin de Mas; P I Johansson
Journal:  Sci Rep       Date:  2022-08-02       Impact factor: 4.996

Review 8.  Precision medicine: The future of diagnostic approach to pulmonary hypertension?

Authors:  Piotr Kedzierski; Adam Torbicki
Journal:  Anatol J Cardiol       Date:  2019-09       Impact factor: 1.596

9.  High geographic prevalence of pulmonary artery hypertension: associations with ethnicity, drug use, and altitude.

Authors:  Jason Dubroff; Lana Melendres; Yan Lin; Daniel Raley Beene; Loren Ketai
Journal:  Pulm Circ       Date:  2020-02-04       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.